BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer

  September 9, 2024

   · 

  7 min read
• Press Releases

  ScribeEMR Introduces New ScribeRyte AI Technology that Automates Clinical Notetaking, Increases Revenue and Reduces Scribing Hours

  September 9, 2024

   · 

  4 min read
• Press Releases

  Owl Therapeutics to present novel approach to Unlocking the Traumatic Brain Injury Market

  September 9, 2024

   · 

  3 min read
• FDA

  Stealth BioTherapeutics Announces FDA Advisory Committee Meeting to Review Elamipretide for Barth Syndrome Treatment

  September 9, 2024

   · 

  3 min read
• Press Releases

  Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA (icosapent ethyl) in Patients with Diabetes and High Cardiovascular Risk and the Anti-Lp(a) Oxidation Mechanistic Effect of Eicosapentaenoic Acid (EPA) to be Presented at the 60th Annual European Association for the Study of Diabetes (EASD) Meeting

  September 9, 2024

   · 

  8 min read
• Press Releases

  Somite Therapeutics and OmniaBio Inc. Announce Collaboration to Advance Somite’s Cell Therapy Flagship Program

  September 9, 2024

   · 

  5 min read
• Press Releases

  Protara Therapeutics Announces Completion of First Cohort in Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations

  September 9, 2024

   · 

  7 min read
• Press Releases

  Creyon Bio Appoints Venture Capitalists Serge Messerlian and Shaquille Vayda to Board of Directors

  September 9, 2024

   · 

  3 min read
• Drug Development

  Libtayo® (cemiplimab) Demonstrates Durable Survival Benefit at Five Years in Advanced Non-small Cell Lung Cancer

  September 9, 2024

   · 

  20 min read
• Press Releases

  Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma

  September 9, 2024

   · 

  7 min read